LuSeed’s device is designed to for ease-of-use, implantation safety, acute treatment and long-term stability via a unique device design, The Device it is placed inside the aneurysm and provides an immediate blockage blood flow into the aneurysm via a dense mesh formation. The device’s unique structure allows easy and intuitive implantation from various angles, which can be used uniquely for sidewall aneurysms – a category so far not relevant for intrasaccular devices and covers 30% of devices’ market. The device is intended to treat both ruptured and unruptured cases, with no significant presence at the parent artery – mitigating unwanted usage of anticoagulants.

Health & Wellness

Health Care

Biotechnology

LuSeed Vascular

LuSeed Vascular's headquarters in Petah Tiqva, Israel

��

People (2)

Jobs (0)

Other offices

��������

People (2)

Jobs (0)

Other offices

��